DreaMed Diabetes technology to be used in Medtronic insulin pump

April 6, 2015 8:08 AM

15 0

TEL AVIV, April 6 (Reuters) - Israel-based DreaMed Diabetes said on Monday it had licensed its artificial pancreas technology for integration into insulin pumps made by Medtronic .

DreaMed will receive undisclosed royalties from future sales of each device using its technology. Medtronic will be responsible for the development and marketing of the pumps.

Read more

To category page